Unlike Viagra, which affects blood flow to the genitals, Addyi is designed to help women regain their sex drive by boosting levels of brain chemicals. Viagra starts to work after one hour, flibanserin needs months of treatment to work. Studies record that Viagra is very effective while testers of the female form say the results are modest.
Sprout said trials had shown an increase "in the number of satisfying sexual events", although experts suggest the test results were modest.
Versions of the pill have been submitted for approval in the past but never passed.
It was rejected by the FDA twice for lack of effectiveness and side effects like nausea, dizziness and fainting.
The drug is meant to treat hypoactive sexual desire disorder (HSDD), a "persistent absence of sexual thoughts, fantasies, responsiveness and willingness to engage in sexual activity." Here's how Sprout Pharmaceuticals describes Addyi:
[A] once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Addyi is the first and only FDA-approved treatment for this condition, the most common form of female sexual dysfunction, affecting up to 1 in 10 women in the United States. Flibanserin has been studied in more than 11,000 women ... For premenopausal women with HSDD, Addyi has demonstrated improvements in desire for sex, reducing distress from the loss of sexual desire and increasing the number of satisfying sexual events.The FDA may have approved the drug, but not without stringent safety restrictions. Addyi will carry warnings about the dangers of taking it with alcohol as well as other medications such as those used to treat yeast infections.
According to Sprout Pharmaceuticals, Addyi could be available on the market as soon as October 17...Read more here
I find this very interesting, what are your thoughts?
Source: www.cosmopolitan.com
www.bbc.com
Comments